FreeTender
Accepting bidsitbItaly

Italy – Administrative Healthcare Services – Procedura Aperta per L’Affidamento AD UNA Contract Research Organization (CRO) DEI Servizi per la Gestione Dello Studio Clinico Multicentrico Randomizzato: “Comboseq - Sequence Strategy of Immuneoncology (Io-Io) VS Io-Tyrosine Kinase Inhibitors (TKI) Followed by TKI in Metastatic Renal Cell Carcinoma (Mrcc): a Randomized Phase 3 Study Meeturo and Ficog

Issued by FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI · via TED — Tenders Electronic Daily (EU)

Published
4 Nov 2026
Closes
24 Nov 2026, 23:59 UTC
Value
EUR 2,024,000
Reference
766672-2026
Location
Italy
Sector
Financial & Professional Services
Type
services

At a glance

FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI in Italy has published an invitation to bid in financial & professional services: “Italy – Administrative Healthcare Services – Procedura Aperta per L’Affidamento AD UNA Contract Research Organization (CRO) DEI Servizi per la Gestione Dello Studio Clinico Multicentrico Randomizzato: “Comboseq - Sequence Strategy of Immuneoncology (Io-Io) VS Io-Tyrosine Kinase Inhibitors (TKI) Followed by TKI in Metastatic Renal Cell Carcinoma (Mrcc): a Randomized Phase 3 Study Meeturo and Ficog”. Submissions close on 24 November 2026, 21 days from today. The stated value is EUR 2,024,000. Quote reference 766672-2026 in any correspondence with the buyer. One document is attached to this notice. FreeTender has recorded 3 notices from this buyer since 2026, 1 of them currently open. There are 253 open financial & professional services notices in Italy on FreeTender. Bids are submitted to the buyer through TED — Tenders Electronic Daily (EU), not through FreeTender.

Details

PROCEDURA APERTA PER L’AFFIDAMENTO AD UNA CONTRACT RESEARCH ORGANIZATION (CRO) DEI SERVIZI PER LA GESTIONE DELLO STUDIO CLINICO MULTICENTRICO RANDOMIZZATO: “COMBOSEQ - SEQUENCE STRATEGY OF IMMUNEONCOLOGY (IO-IO) VS IO-TYROSINE KINASE INHIBITORS (TKI) FOLLOWED BY TKI IN METASTATIC RENAL CELL CARCINOMA (MRCC): A RANDOMIZED PHASE 3 STUDY MEETURO AND FICOG TRIAL”, MEDIANTE PIATTAFORMA SINTEL PREVISTA CLAUSOLA DI ADESIONE EX-POST DEL 300% A FAVORE DEGLI ENTI DEL CONSORZIO, COMPRESA LA FONDAZIONE, DI CUI ALL'ART. 2 DEL DISCIPLINARE DI GARA

Lots Lot 1 — PROCEDURA APERTA PER L’AFFIDAMENTO AD UNA CONTRACT RESEARCH ORGANIZATION (CRO) DEI SERVIZI PER LA GESTIONE DELLO STUDIO CLINICO MULTICENTRICO RANDOMIZZATO: “COMBOSEQ - SEQUENCE STRATEGY OF IMMUNEONCOLOGY (IO-IO) VS IO-TYROSINE KINASE INHIBITORS (TKI) FOLLOWED BY TKI IN METASTATIC RENAL CELL CARCINOMA (MRCC): A RANDOMIZED PHASE 3 STUDY MEETURO AND FICOG TRIAL”, MEDIANTE PIATTAFORMA SINTEL (estimated 2024000.00): PROCEDURA APERTA PER L’AFFIDAMENTO AD UNA CONTRACT RESEARCH ORGANIZATION (CRO) DEI SERVIZI PER LA GESTIONE DELLO STUDIO CLINICO MULTICENTRICO RANDOMIZZATO: “COMBOSEQ - SEQUENCE STRATEGY OF IMMUNEONCOLOGY (IO-IO) VS IO-TYROSINE KINASE INHIBITORS (TKI) FOLLOWED BY TKI IN METASTATIC RENAL CELL CARCINOMA (MRCC): A RANDOMIZED PHASE 3 STUDY MEETURO AND FICOG TRIAL”, MEDIANTE PIATTAFORMA SINTEL PREVISTA CLAUSOLA DI ADESIONE EX-POST A FAVORE DEGLI ENTI DEL CONSORZIO COMPRESA LA FONDAZIONE DEL 300%, COME DA ART. 2 DEL DISCIPLINARE DI GARA

Buyer: FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI

Buyer country: ITA

Procedure: open

CPV code: 75122000

Full notice, tender documents and how to bid are on the official TED page (link above).

Context for bidders

We hold 3 notices from FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI, going back to September 2026 — 1 of them still open. They buy mostly in Healthcare & Pharma and Financial & Professional Services. There are 253 open Financial & Professional Services tenders in Italy. This one closes in 21 days.

Documents

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this financial & professional services opportunity. Always verify the details on the official source.

  • Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
  • Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
  • Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
  • Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
  • Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
  • Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.

More Financial & Professional Services tenders

All Financial & Professional Services tenders →

FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.

Verify & apply on the official portal →